FASTER Act of 2023

The FASTER Act of 2023, also known as Bill 118 hr 4689, is a piece of legislation introduced in the US Congress aimed at improving food allergy awareness and research. The bill seeks to address the growing prevalence of food allergies in the United States by expanding research efforts, improving labeling requirements, and increasing access to potentially life-saving treatments.

One of the key provisions of the FASTER Act is the establishment of a national food allergy registry, which would collect data on the prevalence and impact of food allergies across the country. This registry would help researchers better understand the causes of food allergies and develop more effective treatments.

The bill also includes measures to improve food labeling requirements, such as mandating the disclosure of all potential allergens on food packaging. This would help individuals with food allergies make more informed choices about the foods they consume and reduce the risk of accidental exposure. Additionally, the FASTER Act aims to increase access to epinephrine, a life-saving medication used to treat severe allergic reactions. The bill would require schools and other public facilities to maintain a supply of epinephrine and train staff on how to administer the medication in case of an emergency. Overall, the FASTER Act of 2023 represents a comprehensive effort to address the growing public health concern of food allergies in the United States. By improving awareness, research, and access to treatment, this legislation has the potential to significantly improve the lives of individuals living with food allergies.